Form 4: ACME UNITED CEO Exercises Options, Receives New Grant

Sentiment:

Insider Transaction Report


ACME United Corp's Chairman and CEO, Walter C. Johnsen, exercised 30,000 stock options and was granted 25,000 new options.

Summary

  • Walter C. Johnsen, Chairman and CEO of ACME United Corp, exercised 30,000 employee stock options on February 27, 2026, with an exercise price of $21.49 per share.
  • This transaction involved a net cash settlement directly with the issuer, resulting in a reported disposition of 30,000 common shares at $45.88 per share to cover exercise costs and taxes, without the actual issuance of underlying common stock.
  • Following this exercise, Johnsen's direct beneficial ownership of common stock decreased to 314,999 shares.
  • On March 2, 2026, Johnsen was granted 25,000 new employee stock options with an exercise price of $44.77 per share.
  • These new options will vest in four equal annual installments of 6,250 shares each, commencing March 2, 2027, and fully vesting by March 2, 2030.
  • His beneficial ownership of derivative securities (employee stock options) increased to 413,500 after the new grant.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive, reflecting routine executive compensation and continued alignment of the CEO's interests with long-term company performance through new option grants, despite the net settlement of exercised options.

Positives

  • The grant of 25,000 new employee stock options aligns the CEO's long-term incentives with the company's future performance and shareholder value.
  • The exercise of existing options at a price significantly below the reported disposition price ($21.49 vs. $45.88) indicates a favorable market value for the company's stock at the time of exercise.

Negatives

  • The net cash settlement of 30,000 options means that no additional common stock was added to the CEO's direct beneficial ownership from this specific exercise, resulting in a decrease in reported common stock holdings.

Future Outlook

The grant of new employee stock options with a vesting schedule extending to March 2030 indicates a continued long-term incentive structure for the CEO, aligning his interests with the company's future performance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly by top executives, are closely watched as they can signal management's confidence (or lack thereof) in the company's future prospects. Option exercises and new grants are standard components of executive compensation packages, aligning management interests with shareholder value over the long term.

Related Party Transactions

  • The exercise of the subject option was effected on a net cash settlement basis in a transaction directly with the issuer.

Stakeholder Impact

  • Shareholders: The grant of new options aligns the CEO's long-term incentives with shareholder value. The net settlement of exercised options is a common practice and does not directly dilute existing shares in this specific instance.

Next Steps

  • Vesting of 6,250 shares of new employee stock options on March 2, 2027.
  • Vesting of 6,250 shares of new employee stock options on March 2, 2028.
  • Vesting of 6,250 shares of new employee stock options on March 2, 2029.
  • Vesting of 6,250 shares of new employee stock options on March 2, 2030.

Key Dates

DateDescription
08/03/2020Date exercisable for the 30,000 employee stock options.
02/27/2026Transaction date for the exercise of 30,000 employee stock options and subsequent net cash settlement.
03/02/2026Transaction date for the grant of 25,000 new employee stock options.
08/03/2026Expiration date for the 30,000 employee stock options.
03/02/2027First vesting date for 6,250 shares of the new employee stock options.
03/02/2028Second vesting date for 6,250 shares of the new employee stock options.
03/02/2029Third vesting date for 6,250 shares of the new employee stock options.
03/02/2030Fourth and final vesting date for 6,250 shares of the new employee stock options.
03/02/2036Expiration date for the 25,000 new employee stock options.

Recommendation

hold

This Form 4 details routine executive compensation activities (option exercise and new grant) and does not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. It primarily reflects ongoing management incentives.

Keywords

ACME United Corp, ACU, Walter C. Johnsen, Form 4, insider trading, stock options, CEO, beneficial ownership, equity compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.